2-chloro-4,6-dinaphthalen-2-yl-1,3,5-triazine

We are 2-chloro-4,6-dinaphthalen-2-yl-1,3,5-triazine CAS:1247124-77-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-chloro-4,6-dinaphthalen-2-yl-1,3,5-triazine
CAS.NO:1247124-77-1
Synonyms:2-Chloro-4,6-di(naphthalen-2-yl)-1,3,5-triazine
Molecular Formula:C23H14ClN3
Molecular Weight:367.83000
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

2-chloro-4,6-dinaphthalen-2-yl-1,3,5-triazine


Related News: On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate CAS:172336-32-2 On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.452-71-1 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.1- (2 ', 5'-DICLOROFENIL) -3-METIL-5-PIRAZOLONA CAS:13102-34-6 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.

Related Products
Product Name
Tert-Butyl 1-(bromomethyl)cyclopropyl Carbamate Cas:387845-49-0 View Details
3-Bromo-Benzo[B]Thiophene Cas:7342-82-7 View Details
BISPHENOL S Cas:80-09-1 View Details
Depofemin Cas:313-06-4 manufacturer N-(1-NAPHTHYL)ETHYLENEDIAMINE DIHYDROCHLORIDE Cas:1465-25-4 manufacturer 4-Glycidyloxycarbazole manufacturer 3-iodo-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide manufacturer 2-(Dimethylamino)-2-phenyl Butan-1-ol Cas:39068-94-5 manufacturer